Erratum to Pid1 Induces Insulin Resistance in Both Human and Mouse Skeletal Muscle during Obesity (Mol Endocrinol, 2013, 27, (1518-1535) 10.1210/me.2013-1048);Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity

Molecular Endocrinology

Volumn 27, Issue 9, 2013, Pages 1518-1535

  Bonala, Sabeera ^a,b   McFarlane, Craig ^b   Ang, Jackie ^b   Lim, Radiance ^b   Lee, Marcus ^b   Chua, Hillary ^b   Lokireddy, Sudarsanareddy ^a   Sreekanth, Patnam ^a   Leow, Melvin Khee Shing ^b,c   Khoo, Chin Meng ^d   Tai, E Shyong ^d   Lee, Yung Seng ^d   Gluckman, Peter D ^b   Sharma, Mridula ^d   Kambadur, Ravi ^a,c  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MYOSTATIN; PHOSPHOTYROSINE INTERACTING DOMAIN 1 PROTEIN; PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AGAR GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BINDING SITE; BLOOD SAMPLING; BODY MASS; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTAKE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOBLOTTING; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIVER; MALE; MICROARRAY ANALYSIS; MOUSE; MUSCLE BIOPSY; MUSCLE MITOCHONDRION; MYOBLAST; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; UPREGULATION; VECTOR CONTROL; WESTERN BLOTTING;

MUS;

ADULT; ANIMALS; CARRIER PROTEINS; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; MYOBLASTS; MYOSTATIN; NF-KAPPA B; OBESITY; PALMITIC ACID; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 84883227182     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2013-1048     Document Type: Erratum

References (47)

1. Dubuc PU. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism. 1976;25:1567-1574.
2. Lois K, Kumar S. Obesity and diabetes. Endocrinol Nutr. 56(Suppl. 4):38-42.
3. Masharani UB, Maddux BA, Li X, et al. Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle. PLoS One. 2011;6:e19878.
4. Wang B, Zhang M, Ni YH, et al. Identification and characterization of NYGGF4, a novel gene containing a phosphotyrosine-binding (PTB) domain that stimulates 3T3-L1 preadipocytes proliferation. Gene. 2006;379:132-140.
5. Zhang CM, Chen XH, Wang B, et al. Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt. Acta Pharmacol Sin. 2009;30: 120-124.
6. Zhang CM, Zeng XQ, Zhang R, et al. Effects of NYGGF4 knockdown on insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes. J Bioenerg Biomembr. 2010;42:433-439.
7. Zhao YP, Zhang CM, Zhu C, et al. NYGGF4 homologous gene expression in 3T3-L1 adipocytes: regulation by FFA and adipokines. Mol Biol Rep. 2010;37:3291-3296.
8. Wu WL, Gan WH, Tong ML, et al. Over-expression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway. Mol Genet Metab. 2011;102: 374-377.
9. Zeng XQ, Zhang CM, Tong ML, et al. Knockdown of NYGGF4 increases glucose transport in C2C12 mice skeletal myocytes by activation IRS-1/PI3K/AKT insulin pathway. J Bioenerg Biomembr. 2012;44:351-355.
10. Lokireddy S, Mouly V, Butler-Browne G, et al. Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins. Am J Physiol Cell Physiol. 2011;301:C1316-C1324.
11. Zhang C, McFarlane C, Lokireddy S, et al. Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMPactivated protein kinase signalling pathway. Diabetologia. 2011; 54:1491-1501.
12. Zhang C, McFarlane C, Lokireddy S, et al. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia. 2012;55:183-193.
13. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 1977;270: 725-727.
14. Bigot A, Jacquemin V, Debacq-Chainiaux F, et al. Replicative aging down-regulates the myogenic regulatory factors in human myoblasts. Biol Cell. 2008;100:189-199.
15. Jacquemin V, Furling D, Bigot A, Butler-Browne GS, Mouly V. IGF-1 induces human myotube hypertrophy by increasing cell recruitment. Exp Cell Res. 2004;299:148-158.
16. McFarlane C, Hui GZ, Amanda WZ, et al. Human myostatin negatively regulates human myoblast growth and differentiation. Am J Physiol Cell Physiol. 2011;301:C195-C203.
17. McFarlane C, Plummer E, Thomas M, et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κB-independent, FoxO1-dependent mechanism. J Cell Physiol. 2006;209:501-514.
18. Chavez JA, Knotts TA, Wang LP, et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem. 2003;278:10297-10303.
19. Lokireddy S, McFarlane C, Ge X, et al. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting. Mol Endocrinol. 2011;25: 1936-1949.
20. Lokireddy S, Wijesoma IW, Teng S, et al. The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell metabolism. 2012;16:613-624.
21. Bonala S, Lokireddy S, Arigela H, et al. Peroxisome proliferatoractivated receptorα/β induces myogenesis by modulating myostatin activity. J Biol Chem. 2012;287:12935-12951.
22. Furalyov VA, Kravchenko IV, Khotchenkov VP, Popov VO. siRNAs targeting mouse myostatin. Biochemistry (Mosc). 2008;73: 342-345.
23. Sriram S, Subramanian S, Sathiakumar D, et al. Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB. Aging Cell. 2011;10:931-948.
24. Yang YL, Xiang RL, Yang C, et al. Gene expression profile of human skeletal muscle and adipose tissue of Chinese Han patients with type 2 diabetes mellitus. Biomed Environ Sci. 2009;22:359-368.
25. Hwang H, Bowen BP, Lefort N, et al. Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes. 2010;59:33-42.
26. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes. 2002;51:1913-1920.
27. Larrouy D, Barbe P, Valle C, et al. Gene expression profiling of human skeletal muscle in response to stabilized weight loss. Am J Clin Nutr. 2008;88:125-132.
28. Yokoi N, Fujiwara Y, Wang HY, et al. Identification and functional analysis of CBLB mutations in type 1 diabetes. Biochem Biophys Res Commun. 2008;368:37-42.
29. Kosoy R, Yokoi N, Seino S, Concannon P. Polymorphic variation in the CBLB gene in human type 1 diabetes. Genes Immun. 2004;5: 232-235.
30. Tan CK, Leuenberger N, Tan MJ, et al. Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet. Diabetes. 2011;60:464-476.
31. Nadeau KJ, Ehlers LB, Aguirre LE, et al. Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle. Am J Physiol Endocrinol Metab. 2006;291:E90-E98.
32. Sewter C, Berger D, Considine RV, et al. Human obesity and type 2. diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-α. Diabetes. 2002;51:1035-1041.
33. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-334.
34. Takada F, Vander Woude DL, Tong HQ, et al. Myozenin: an α-actinin-and γ-filamin-binding protein of skeletal muscle Z lines. Proc Natl Acad Sci USA. 2001;98:1595-1600.
35. Kvezereli M, Michie SA, Yu T, Creusot RJ, Fontaine MJ. TSG-6 protein expression in the pancreatic islets of NOD mice. J Mol Histol. 2008;39:585-593.
36. Carvalho E, Jansson PA, Axelsen M, et al. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J. 1999;13:2173-2178.
37. Hedbacker K, Birsoy K, Wysocki RW, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab. 2010;11:11-22.
38. Liu W, Singh R, Choi CS, et al. Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure. J Biol Chem. 2012;287:7213-7223.
39. Allen DL, Cleary AS, Speaker KJ, et al. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab. 2008;294:E918-E927.
40. Chen Y, Cao L, Ye J, Zhu D. Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin. Biochem Biophys Res Commun. 2009;388:112-116.
41. Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes. 2009;58:30-38.
42. Zhao Y, Zhang C, Chen X, et al. Overexpression of NYGGF4 (PID1) induces mitochondrial impairment in 3T3-L1 adipocytes. Mol Cell Biochem. 2010;340:41-48.
43. Zhao YP, Zhang CM, Zhu C, et al. NYGGF4 homologous gene expression in 3T3-L1 adipocytes: regulation by FFA and adipokines. Mol Biol Rep. 2010;37:3291-3296.
44. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917-923.
45. Wu WL, Gan WH, Tong ML, et al. Over-expression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway. Mol Genet Metab. 2011;102: 374-377.
46. Zhang CM, Chen XH, Wang B, et al. Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt. Acta Pharmacol Sin. 2009;30: 120-124.
47. Zhang CM, Qiu J, Chen XH, Wang B, Zhang M, Guo XR. [Effects of NYGGF4 gene over-expression on the insulin sensitivity and secretory function of adipocytes]. Zhongguo Dang Dai Er Ke Za Zhi. 2009;11:846-849.